Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock, Warrants to Placement Agent and Shareholders' Equity (Unaudited)

v3.23.3
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock, Warrants to Placement Agent and Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Warrants to Placement Agent
Redeemable Convertible Preferred Stock
Common Stock
Non-voting Common Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2021 $ 5,585 [1] $ 2,824 $ (22,420) $ (19,596)
Balance (in Shares) at Dec. 31, 2021 [2]   773,108 205,040 178,377      
Exercise of options into common stock [1]   [1]   [1]
Exercise of options into common stock (in Shares) [2]     1,546        
Share based compensation     14   14
Net comprehensive loss for the period     (4,639) (4,639)
Balance at Mar. 31, 2022 $ 5,585 [1] 2,838 [2] (27,059) (24,221)
Balance (in Shares) at Mar. 31, 2022 [2]   773,108 206,586 178,377      
Balance at Dec. 31, 2021 $ 5,585 [1] 2,824 (22,420) (19,596)
Balance (in Shares) at Dec. 31, 2021 [2]   773,108 205,040 178,377      
Net comprehensive loss for the period             (8,500)
Balance at Sep. 30, 2022 [2] $ 1 36,482 (30,920) 5,563
Balance (in Shares) at Sep. 30, 2022 [2]   1,731,755      
Balance at Mar. 31, 2022 $ 5,585 [1] 2,838 [2] (27,059) (24,221)
Balance (in Shares) at Mar. 31, 2022 [2]   773,108 206,586 178,377      
Share based compensation 14 14
Conversion of convertible preferred stock to common stock upon initial public offering $ (5,585) $ 1 5,584 5,585
Conversion of convertible preferred stock to common stock upon initial public offering (in Shares) [2]   (773,108) 773,108      
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs [1] 14,675 14,675
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs (in Shares) [2]   421,250      
Conversion of convertible loan to common stock upon initial public offering [1] 6,553 6,553
Conversion of convertible loan to common stock upon initial public offering (in Shares) [2]   163,816      
Conversion of convertible note to common stock upon initial public offering [1] 3,600 3,600
Conversion of convertible note to common stock upon initial public offering (in Shares) [2]   90,009      
Conversion of warrants to common stock upon initial public offering [1] 3,190 3,190
Conversion of warrants to common stock upon initial public offering (in Shares) [2]   79,756      
Redemption of non-voting common stock upon initial public offering [1]
Redemption of non-voting common stock upon initial public offering (in Shares) [2]   (178,377)      
Repurchase of common stock [1] 15 15
Repurchase of common stock (in Shares) [2]     (2,770)      
Net comprehensive loss for the period (1,654) (1,654)
Balance at Jun. 30, 2022 $ 1 [2] 36,469 (28,713) 7,757
Balance (in Shares) at Jun. 30, 2022 [2]   1,731,755      
Share based compensation         13   13
Net comprehensive loss for the period           (2,207) (2,207)
Balance at Sep. 30, 2022 [2] $ 1 36,482 (30,920) 5,563
Balance (in Shares) at Sep. 30, 2022 [2]   1,731,755      
Balance at Dec. 31, 2022 [2] [2] $ 1 [2] [2] 36,666 [2] (33,402) [2] $ 3,265 [3]
Balance (in Shares) at Dec. 31, 2022   [2] 1,737,986 [2] [2]     1,737,986 [3]
Share based compensation 95 $ 95
Repurchase of common stock [1] (50) (50)
Repurchase of common stock (in Shares) [2]   (7,920)      
Net comprehensive loss for the period (1,895) (1,895)
Balance at Mar. 31, 2023 $ 1 [2] 36,711 [2] (35,297) 1,415
Balance (in Shares) at Mar. 31, 2023 [2]   1,730,066      
Balance at Dec. 31, 2022 [2] [2] $ 1 [2] [2] 36,666 [2] (33,402) [2] $ 3,265 [3]
Balance (in Shares) at Dec. 31, 2022   [2] 1,737,986 [2] [2]     1,737,986 [3]
Net comprehensive loss for the period             $ (4,355)
Balance at Sep. 30, 2023 104 [2] [2] $ 1 [2] [2] 38,594 [2] (37,757) [2] $ 838 [3]
Balance (in Shares) at Sep. 30, 2023   [2] 2,694,179 [2] [2]     2,694,179 [3]
Balance at Mar. 31, 2023 $ 1 [2] 36,711 [2] (35,297) $ 1,415
Balance (in Shares) at Mar. 31, 2023 [2]   1,730,066      
Exercise of options into common stock [1] 10 10
Exercise of options into common stock (in Shares) [2]     10,652        
Share based compensation   97 97
Share based compensation (in Shares) [2]            
Issuance of common stock and pre-funded warrants upon private placement, net of underwriting commissions and other offering costs 104 [1] 1,356 1,356
Issuance of common stock and pre-funded warrants upon private placement, net of underwriting commissions and other offering costs (in Shares) [2]   190,000      
Net comprehensive loss for the period (1,593) (1,593)
Balance at Jun. 30, 2023 104 $ 1 38,174 (36,890) 1,285
Balance (in Shares) at Jun. 30, 2023 [2]   1,930,718      
Exercise of options into common stock [1]        
Exercise of options into common stock (in Shares) [2]     8,791        
Exercise of pre-funded warrants into common stock [1] [1] [1]
Exercise of pre-funded warrants into common stock (in Shares) [2]     754,670      
Reclassification of warrants from liabilities to equity (see note (11(d))         314   314
Reclassification of warrants from liabilities to equity (see note (11(d)) (in Shares) [2]          
Share based compensation         106   106
Net comprehensive loss for the period           (867) (867)
Balance at Sep. 30, 2023 $ 104 [2] [2] $ 1 [2] [2] $ 38,594 [2] $ (37,757) [2] $ 838 [3]
Balance (in Shares) at Sep. 30, 2023   [2] 2,694,179 [2] [2]     2,694,179 [3]
[1] Represents an amount less than $1 thousands.
[2] Adjusted to reflect reverse stock split, see note 3(f).
[3] Adjusted to reflect reverse stock split, see note 3(f).